?(en)

---

Publications du groupe

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
ANNALS OF THE RHEUMATIC DISEASES
2009 vol. 68(1) pp. 33-39
FINCKH A, DEHLER S, GABAY C

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
ANNALS OF THE RHEUMATIC DISEASES
2009 vol. 69(2) pp. 387-393
FINCKH A, CIUERA A, BRULHART L, MÖLLER B, WALKER UA, COURVOISIER D, KYBURZ D, DUDLER J, GABAY C

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis.
ARTHRITIS AND RHEUMATISM --
2009 vol. 61(5) pp. 560-568
MARTIN-DU-PAN S, DEHLER S, CIUREA A, ZISWILER HR, GABAY C, FINCKH A

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
ARTHRITIS AND RHEUMATISM --
2009 vol. 60(3) pp. 738-749
PALMER G, TALABOT-AYER D, LAMACCHIA C, TROY D, SEEMAYER C, SIATTE S, FINCKH A, SMITH DE, GABAY C

Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice.
ARTHRITIS RESEARCH & THERAPY
2009 vol. 11(3) pp. 72-72
BUTOESCU N, SEEMAYER C, PALMER G, GUERNE PA, GABAY C, DOELKER E, JORDAN O

Synovial tissues concentrate secreted APRIL.
ARTHRITIS RESEARCH & THERAPY
2009 vol. 11(5) pp. 144-144
GABAY C, KRENN V, BOSSHARD C, SEEMAYER CA, CHIZZOLINI C, HUARD B

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases.
ARTHRITIS RESEARCH & THERAPY
2009 vol. 11(3) pp. 230-230
GABAY C, MCINNES IB

Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2009 vol. 27(5) pp. 885-886
BAS S, NEFF L, VIATTE S, VUILLET M, SPENATO U, GUERNE PA, MICHEL M, TIERCY JM, BUTRIMIENE I, GABAY C

Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaound-Cameroon
CLINICAL RHEUMATOLOGY
2009 vol. 28(4) pp. 465-468
NGANDEU M, NDOBO P, GABAY C

Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
JOINT BONE SPINE
2009 vol. 76(4) pp. 424-426
ANNOUN N, PALMER G, GUERNE PA, GABAY C

Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
JOURNAL OF BIOLOGICAL CHEMISTRY
2009 vol. 284(29) pp. 19420-19426
TALABOT-AYER D, LAMACCHIA C, GABAY C, PALMER G

Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory
JOURNAL OF IMMUNOLOGY
2009 vol. 182(8) pp. 4728-4736
ZIMMERLI C, LEE BP, PALMER G, GABAY C, ADAMS R, AURRAND-LIONS M, IMHOF B

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies.
SWISS MEDICAL WEEKLY
2009 vol. 39(3-4) pp. 41-46
BANDELIER C, GUERNE PA, GENEVAY S, FINCKH A, GABAY C

At the horizon of innovative therapy in rheumatology: new biologic agents.
CURRENT OPINION IN RHEUMATOLOGY
2008 vol. 20(3) pp. 269-275
FINCKH A, GABAY C

The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
CYTOKINE
2008 vol. 42(3) pp. 358-364
PALMER G, LIPSKY BP, SMITHGALL MD, MEININGER D, SIU S, TALABOT-AYER D, GABAY C, SMITH DE

IL-1, IL-18, and IL-33 families of cytokines.
IMMUNOLOGICAL REVIEWS
2008 vol. 223 pp. 20-38
AREND WP, PALMER G, GABAY C

The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR 6 and CD14.
JOURNAL OF IMMUNOLOGY
2008 vol. 180(2) pp. 1158-1168
BAS S, NEFF L, VUILLET M, SPENATO U, SEYA T, MATSUMOTO M, GABAY C

Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
NATURE CLINICAL PRACTICE RHEUMATOLOGY
2008 vol. 4(11) pp. 572-573
GABAY C

Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2008 vol. 43(11) pp. 1360-1365
LUDWICZEK O, VANNIER E, MOSCHEN A, SALAZAR-MONTES A, BORGGRAEFE I, GABAY C, ENRICH B, KASER A, SIEGMUND B, DINARELLO C, TILG H

Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc.
SPINE
2008 vol. 33(19) pp. 2041-2046
GENEVAY S, FINCKH A, PAYER M, MEZIN F, TESSITORE E, GABAY C, GUERNE PA

Cigarette smoking and radiographic progression in rheumatoid arthritis
ANNALS OF THE RHEUMATIC DISEASES
2007 vol. 66 pp. 1066-1071
FINCKH A, DEHLER S, COSTENBADER KH, GABAY C

Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: A population-based cohort study
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
2007 vol. 57 pp. 679-685
GENEVAY, S, FINCKH, A, CIUREA, A, CHAMOT, AM, KYBURZ, D, GABAY, C

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
ARTHRITIS AND RHEUMATISM --
2007 vol. 56(5) pp. 1417-1423
FINCKH A, CIUREA A, BRULHART L, KYBURZ D, MÖLLER B, DEHLER S, REVAZ SA, DUDLER J, GABAY C

Expression and function of junctional adhesion molecule-C in human and experimental arthritis.
ARTHRITIS RESEARCH & THERAPY
2007 vol. 9(4) pp. 65-
PALMER G, BUSSO N, AURRAND-LIONS M, TALABOT-AYER D, CHOBAZ-PÉCLAT V, ZIMMERLI C, HAMMEL P, IMHOF BA, GABAY C

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
CYTOKINE
2007 vol. 40(3) pp. 216-225
MOULIN D, DONZÉ O, TALABOT-AYER D, MÉZIN F, PALMER G, GABAY C

Oligopeptide antagonist of IL-6: a novel approach to target IL-6 activities
EXPERT OPINION ON THERAPEUTIC PATENTS
2007 vol. 17 pp. 1309-1314
GABAY C

Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein
JOURNAL OF BACTERIOLOGY
2007 vol. 189 pp. 4739-4748
NEFF L, DAHER S, MUZZIN P, SPENATO U, GULACAR F, GABAY C, BAS S

Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation
JOURNAL OF INVESTIGATIVE DERMATOLOGY
2007 vol. 127 pp. 1938-1946
PALMER G, TALABOT-AYER D, KAYA G, GABAY C

Discrimination of C57BL/6J Rj and 129S2/SvPasCrl inbred mouse strains by use of simple sequence length polymorphisms.
JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE
2007 vol. 46(2) pp. 21-24
LAMACCHIA C, PALMER G, GABAY C

Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis
RHEUMATOLOGY INTERNATIONAL
2007 vol. 27 pp. 793-806
EMERY P, GABAY C, KRAAN M, GOMEZ-REINO J

Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study
ANNALS OF THE RHEUMATIC DISEASES
2006 vol. 65 pp. 1255-1257
BRULHART L, CIUREA A, FINCKH A, NOTTER A, WALDBURGER JM, KYBURZ D, GABAY C

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
ANNALS OF THE RHEUMATIC DISEASES
2006 vol. 65 pp. 746-752
FINCKH A, SIMARD JF, GABAY C, GUERNE PA

Rituximab in the treatment of antisynthetase syndrome
ANNALS OF THE RHEUMATIC DISEASES
2006 vol. 65 pp. 974-975
BRULHART L, WALDBURGER JM, GABAY C

Leukocyte migration to rheumatoid joints: Enzymes take over
ARTHRITIS AND RHEUMATISM --
2006 vol. 54 pp. 2707-2710
PALMER G, GABAY C, IMHOF BA

Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis
ARTHRITIS AND RHEUMATISM --
2006 vol. 55 pp. 864-872
FINCKH A, LIANG MH, VAN HERCKENRODE CM, DE PABLO P

Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis - A longitudinal study
ARTHRITIS AND RHEUMATISM --
2006 vol. 54 pp. 1444-1450
FINCKH A, DE PABLO P, KATZ JN, NEUMANN G, WOLFE F, DURYEA J

Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration
ARTHRITIS AND RHEUMATISM --
2006 vol. 54 pp. 1440-1443
GOLIGHER EC, DURYEA J, LIANG MH, WOLFE F, FINCKH A

The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study
ARTHRITIS AND RHEUMATISM --
2006 vol. 54(1) pp. 54-59
FINCKH A, SIMARD JF, DURYEA J, LIANG MH, HUANG J, DANEEL S, FORSTER A, GABAY C, GUERNE PA, THE SCQM PROGRAM

Interleukin-6 and chronic inflammation
ARTHRITIS RESEARCH & THERAPY
2006 vol. 8 pp. 0-0
GABAY C

The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes
ARTHRITIS RESEARCH & THERAPY
2006 vol. 8 pp. 0-0
MAGNE D, PALMER G, BARTON JL, MEZIN F, TALABOT-AYER D, BAS S, DUFFY T, NOGER M, GUERNE PA, NICKLIN MJH, GABAY C

The role of leptin in innate and adaptive immune responses
ARTHRITIS RESEARCH & THERAPY
2006 vol. 8(5) pp. 217-217
BERNOTIENE EIVA, PALMER-LOURENCO GABY, GABAY CEM

Is IL-I a good therapeutic target in the treatment of arthritis?
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
2006 vol. 20 pp. 879-896
BURGER D, DAYER JM, PALMER G, GABAY C

Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2006 vol. 146(2) pp. 287-293
MARRINOVA-MUTAFCHIEVA L, GABAY C, FUNA K, WILLIAMS RO

Henoch Schonlein purpura following etanercept treatment of rheumatoid arthritis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2006 vol. 24 pp. 106-106
DUFFY TN, GENTA M, MOLL S, MARTIN PY, GABAY C

Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community
JOINT BONE SPINE
2006 vol. 73 pp. 51-56
GENTA MS, KARDES H, GABAY C

Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice
JOURNAL OF IMMUNOLOGY
2006 vol. 177 pp. 2899-2907
PALMER G, AURRAND-LIONS M, CONTASSOT E, TALABOT-AYER D, DUCREST-GAY D, VESIN C, CHOBAZ-PECLAT V, BUSSO N, GABAY C

Milwaukee shoulder
NEW ENGLAND JOURNAL OF MEDICINE
2006 vol. 354 pp. 2-2
GENTA MS, GABAY C

Systemic rheumatoid vasculitis: A review
SEMINARS IN ARTHRITIS AND RHEUMATISM
2006 vol. 36 pp. 88-98
GENTA MS, GENTA RM, GABAY C

The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation
VITAMINS AND HORMONES
2006 vol. 74 pp. 371-403
JACQUES CLAIRE, GOSSET MARJOLAINE, BERENBAUM FRANCIS, GABAY CEM

Evidence for differential acquired drug resistance to anti-TNF agents in rheumatoid arthritis
ANNALS OF THE RHEUMATIC DISEASES
2005 vol. Dec 8 pp. 0-0
FINCKH AXEL, SIMARD J.F., GABAY CEM, GUERNE PIERRE-ANDRE

Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community
JOINT BONE SPINE
2005 vol. Dec 5 pp. 51-56
GENTA M.S., KARDES H., GABAY CEM

Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis
EUROPEAN JOURNAL OF IMMUNOLOGY
2003 vol. 33 pp. 434-440
PALMER-LOURENCO G, TALABOT D, SZALAY-QUINODOZ I, MARET M, AREND WP, GABAY C

An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis
ANNALS OF THE RHEUMATIC DISEASES
2002 vol. 61 pp. 734-736
GENEVAY S, HAYEM G, VERPILLAT P, MEYER O

Primary human articular chondrocytes, dedifferentiated chondrocytes, and synoviocytes exhibit differential responsiveness to interleukin-4: correlation with the expression pattern of the common recept or gamma chain
JOURNAL OF CELLULAR PHYSIOLOGY
2002 vol. 192 pp. 93-101
GUICHEUX J, PALMER-LOURENCO G, RELIC B, MEZIN F, CAVERZASIO J, APOSTOLIDES P, GAUCHAT JF, GABAY C, GUERNE PA

Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis
JOURNAL OF IMMUNOLOGY
2002 vol. 168 pp. 875-882
BUSSO N, CHOBAZ-PÉCLAT V, MORARD C, MARTINEZ-SORIA E, TALABOT D, GABAY C

Oculomotor palsy in six patients with systemic lupus erythematous. A possible role of antiphospholipid syndrome
LUPUS
2002 vol. 11 pp. 313-316
GENEVAY S, HAYEM G, HAMZA S, PALAZZO E, MEYER O, KAHN MF

---

Domaines de recherche